1802
S. Shahzadi et al. / Journal of Organometallic Chemistry 691 (2006) 1797–1802
˚
˚
2.485(8) A, in 2 Sn–Cl(1) 2.467(6) A) lie in the range of the
Acknowledgment
˚
normal covalent radii, 2.37–2.60 A [12,13,18].
Saqib Ali is thankful to Quaid-i-Azam University,
Islamabad for financial support.
3.6. Microbial assay
The free ligand 4-methyl-1-piperidine carbodithioic acid
and their chloro-diorganotin(IV) complexes were tested
against the bacterial strains Escherichia coli, Bacillus sub-
tilis, Shigella flexenari, Staphylococcus aureus, Pseudomo-
nas aeruginosa and Salmonella typhi by agar well
diffusion method [19] and the antifungal activity against
Trichophyton longifusus, Candida albicans, Aspergillus
flavus, Microsporum canis, Fusarium solani and Candida
glaberata. The results are listed in Table 3.
The antibacterial studies exhibited that the complexes 1–
3 have high activity towards all tested bacteria than the free
ligand. The antifungal studies by tube diffusion method
exhibited that the complexes 1–3 have high activity towards
all the tested fungi than the free ligand. It may be con-
cluded that metal coordination increases the activity as
compared to free ligand.
References
[1] E.I. Stiefel, K. Matsumoto, in: Transition Metal Sulfur Chemistry
ASC Symposium Series, vol. 653, American Chemical Society,
Washington, DC, 1995, p. 2.
[2] P. Yang, M. Guo, Coord. Chem. Rev. 189 (1999) 185.
[3] R.K. Chadha, R. Kumar, D.G. Tuck, Can. J. Chem. 65 (1987) 1336.
[4] T.A. Al-Allaf, I.A. Mustafa, S.E. Al-Mukhtar, Transition Met.
Chem. 18 (1993) 1.
[5] R.T. Dorr, in: H.M. Pinedo, J.H. Schornagel (Eds.), Platinum and
Other Metal Coordination Compounds in Cancer Chemotherapy,
vol. 2, Plenum Press, New York, 1996, p. 131.
[6] N. Ferrell, Catalysis by Metal ComplexesTransition Metal Com-
plexes as Drugs and Chemotherapeutic Agents, vol. 11, Kluwer
Academic Publishers, Dordrecht, 1989, p. 44.
[7] L. Pellerito, L. Nagy, Coord. Chem. Rev. 224 (2002) 111.
[8] A.K. Saxena, F. Huber, Coord. Chem. Rev. 95 (1989) 109.
[9] M.N. Xanthopoulou, S.K. Hadjikakou, N. Hadjiliadis, M. Schur-
¨
mann, K. Jurkschat, A. Michaelides, S. Skoulika, T. Bakas, J.
Binolis, S. Karkabounas, K. Charalabopoulos, J. Inorg. Biochem. 96
(2003) 425.
4. Conclusions
[10] (a) D.C. Menezes, G.M. de Lima, A.O. Porto, C.L. Donnici, J.D.
Ardisson, A.C. Doriguetto, J. Ellena, Polyhedron 23 (2004) 2103;
(b) R. Sharma, N.K. Kaushik, J. Therm. Anal. Calor. 78 (2004) 953.
[11] A.T. Kana, T.G. Hibbert, M.F. Mahon, K.C. Molloy, I.P. Parkin,
L.S. Price, Polyhedron 20 (2001) 2989.
[12] S. Ali, S.U. Ahmad, S. Rehman, S. Shahzadi, M. Parvez, M. Mazhar,
Appl. Organomet. Chem. 19 (2005) 200.
[13] S. Ali, S.U. Ahmad, S. Shahzadi, S. Rehman, M. Parvez, M. Mazhar,
Appl. Organomet. Chem. 19 (2005) 201.
Chloro-diorganotin(IV) complexes of 4-methyl-1-piperi-
dine carbodithioic acid have been synthesized and charac-
terized. Detailed studies of reported complexes indicate
that their structures are trigonal bipyramidal geometry.
These complexes also checked for their antimicrobial activ-
ity against different bacteria and fungi by agar well diffu-
sion and tube diffusion methods, respectively. The
screening results show that reported compounds 1–3 exhi-
bit high antimicrobial activity as compared to free ligand
(4-methyl-1-piperidine carbodithioic acid).
[14] (a) W.F.F. Armarego, C.L.L. Chai, Purification of Laboratory
Chemicals, fifth ed., Butterworth, Oxford, 2003;
(b) A. Benedetti, A.C. Fabretti, C. Preti, J. Chem. Crystallogr. 18
(1988) 685;
(c) A.C. Fabretti, C. Preti, J. Chem. Crystallogr. 19 (1989) 957.
[15] H.P.S. Chauhan, N.M. Shaik, J. Inorg. Biochem. 99 (2005) 538.
[16] (a) T.P. Lockhart, W.F. Manders, Inorg. Chem. 25 (1986) 892;
(b) B. Wrackmeyer, Annu. Rep. NMR Spectrosc. 16 (1985) 73;
(c) B. Wrackmeyer, Annu. Rep. NMR Spectrosc. 38 (1999) 203.
[17] M.H. Bhatti, S. Ali, M. Mazhar, M. Danish, M.A. Choudhary,
Turk. J. Chem. 23 (1999) 329.
[18] (a) A. Tarassoli, T. Sedaghat, M.L. Helm, A. Norman, J. Coord.
Chem. 56 (2003) 1179;
(b) C. Ma, J. Zhang, R. Zhang, Can. J. Chem. 81 (2003) 1070.
[19] A. Rehman, M.I. Choudhary, W.J. Thomsen, Bioassay Techniques
for Drug Development, Harwood Academic Publishers, The Neth-
erlands, 2001, p. 14.
5. Supplementary material
Crystallographic data for the structural analysis have
been deposited with the Cambridge Crystallographic Data
Centre, CCDC Nos. 277901 and 277900 for complexes 1
and 3, respectively. Copies of these information may be
obtained free of charge from the Director, CCDC, 12
Union Road, Cambridge, CBZ 1EZ, UK (fax: +44 1223
336 033; email: deposit@ccdc.cam.ac.uk or www: http://